Kintegral Advisory LLC Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

04 Jul 2025, 15:52 by Mitch Edgeman · The Markets Daily

Kintegral Advisory LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 32.9% in the 1st quarter, Holdings Channel.com reports. The firm owned 5,518 shares of the healthcare conglomerate’s stock after selling 2,706 shares during the period. Kintegral Advisory LLC’s holdings in UnitedHealth Group were worth $2,890,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG increased its stake in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after purchasing an additional 9,872 shares in the last quarter. NewSquare Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at about $25,000. Finally, Proficio Capital Partners LLC increased its stake in UnitedHealth Group by 52.1% during the 4th quarter. Proficio Capital Partners LLC now owns 3,734 shares of the healthcare conglomerate’s stock worth $1,889,000 after buying an additional 1,279 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other news, CFO John F. Rex bought 17,175 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director owned 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on UNH shares. Piper Sandler dropped their price target on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. Raymond James Financial lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Robert W. Baird lowered UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective on the stock. in a research note on Wednesday, June 11th. Finally, Truist Financial reiterated a “buy” rating and set a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $415.57.

Get Our Latest Report on UnitedHealth Group

UnitedHealth Group Trading Up 0.4%

NYSE UNH opened at $308.69 on Friday. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The firm has a 50 day moving average of $327.18 and a two-hundred day moving average of $448.90. The stock has a market capitalization of $280.03 billion, a PE ratio of 12.93, a price-to-earnings-growth ratio of 1.46 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the business earned $6.91 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.